Fingerprint Dive into the research topics of 'The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease'. Together they form a unique fingerprint.